VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Sunday, January 11, 2026

Wide Moat Stocks Expansion-Stage Stocks Home My Collections

Stock Comparison

Boston Scientific Corporation vs Morningstar, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Boston Scientific Corporation

BSX · New York Stock Exchange

Market cap (USD)$144.7B

Gross margin (TTM)65.1%

Operating margin (TTM)17.3%

Net margin (TTM)14.4%

SectorHealthcare

IndustryMedical - Devices

CountryUS

Data as of2026-01-04

Moat score

65/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Boston Scientific Corporation's moat claims, evidence, and risks.

View BSX analysis

Morningstar, Inc.

MORN · NASDAQ

Market cap (USD)—

Gross margin (TTM)—

Operating margin (TTM)—

Net margin (TTM)—

SectorFinancials

Industry—

CountryUS

Data as of2026-01-10

Moat score

67/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Morningstar, Inc.'s moat claims, evidence, and risks.

View MORN analysis

Comparison highlights

Moat score gap: Morningstar, Inc. leads (67 / 100 vs 65 / 100 for Boston Scientific Corporation).
Segment focus: Boston Scientific Corporation has 5 segments (49.8% in Cardiology); Morningstar, Inc. has 7 segments (34.6% in Morningstar Data and Analytics).
Moat breadth: Boston Scientific Corporation has 6 moat types across 3 domains; Morningstar, Inc. has 6 across 3.

Primary market context

Boston Scientific Corporation

Cardiology

Market

Cardiology devices (interventional cardiology, structural heart, electrophysiology, cardiac rhythm management and remote monitoring)

Geography

Global

Customer

Hospitals/cath labs/EP labs and specialty clinics (cardiologists, electrophysiologists)

Role

Medical device OEM / implantables + procedure devices + service-enabled monitoring

Revenue share

49.8%

Morningstar, Inc.

Morningstar Data and Analytics

Market

Investment data, research, and analytics platforms

Geography

Global

Revenue share

34.6%

Side-by-side metrics

Boston Scientific Corporation

Morningstar, Inc.

Ticker / Exchange

BSX - New York Stock Exchange

MORN - NASDAQ

Market cap (USD)

$144.7B

n/a

Gross margin (TTM)

65.1%

n/a

Operating margin (TTM)

17.3%

n/a

Net margin (TTM)

14.4%

n/a

Sector

Healthcare

Financials

Industry

Medical - Devices

n/a

HQ country

Primary segment

Cardiology

Morningstar Data and Analytics

Market structure

Oligopoly

Market share

n/a

HHI estimate

n/a

Pricing power

Moderate

Moat score

65 / 100

67 / 100

Moat domains

Demand, Legal, Supply

Demand, Network, Legal

Last update

2026-01-04

2026-01-10

Moat coverage

Shared moat types

Training Org Change CostsRegulated Standards Pipe

Boston Scientific Corporation strengths

Installed Base ConsumablesProcurement InertiaReputation ReviewsDistribution Control

Morningstar, Inc. strengths

Data Workflow LockinDe Facto StandardSuite BundlingIP Choke Point

Segment mix

Boston Scientific Corporation segments

Full profile >

Endoscopy

Oligopoly

16%

Urology

Competitive

13.1%

Neuromodulation

Oligopoly

6.6%

Cardiology

Oligopoly

49.8%

Peripheral Interventions

Competitive

14.4%

Morningstar, Inc. segments

Full profile >

Morningstar Data and Analytics

Oligopoly

34.6%

PitchBook

Oligopoly

27.2%

Morningstar Credit

Oligopoly

12.8%

Morningstar Wealth

Competitive

10.9%

Morningstar Retirement

Competitive

5.6%

Morningstar Sustainalytics

Oligopoly

5.2%

Morningstar Indexes

Oligopoly

3.7%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.